focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

TOP NEWS: AstraZeneca welcomes court victory over EU vaccine supply

Fri, 18th Jun 2021 13:49

(Alliance News) - AstraZeneca PLC on Friday welcomed a Brussels court decision over its vaccine supply pact with the EU.

The EU was looking to sue the London-listed pharmaceutical group in a bid to force it to deliver 90 million more doses of its Covid-19 vaccine before July. Astra delivered only 30 million doses in the first quarter out of the 120 million it was contracted to supply.

The Anglo-Swedish pharmaceutical firm on Friday said the European Commission had requested 120 million vaccine doses cumulatively by the end of this month, and a total of 300 million by the end of September.

The judge at the Court of First Instance in Brussels, however, has ordered delivery of just 80.2 million doses by September 27 - a figure Astra expects to "substantially exceed" by the end of June given it has already supplied more than 70 million doses to the EU.

"All other measures sought by the European Commission have been dismissed, and in particular the court found that the European Commission has no exclusivity or right of priority over all other contracting parties," the firm said.

"The judgement also acknowledged that the difficulties experienced by AstraZeneca in this unprecedented situation had a substantial impact on the delay."

Astra said it now looks forward to "renewed collaboration" with the EC.

Jeffrey Pott, general counsel, said: "We are pleased with the court's order. AstraZeneca has fully complied with its agreement with the European Commission and we will continue to focus on the urgent task of supplying an effective vaccine, which we are delivering at no profit to help protect people in Europe and around the world from the deadliest pandemic in a generation."

Recent data has shown Astra's Covid-19 vaccine offers good protection against the Delta variant. Real world data from Public Health England, published as a pre-print, showed two doses of Astra's jab were 92% effective against hospitalisation from the Delta variant and showed no deaths among those vaccinated.

Shares in Astra were trading flat at 8,381.00 pence in London on Friday afternoon.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Related Shares

More News
12 May 2024 13:25

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly ...

8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of Engla...

8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4% *

8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the...

8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemi...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.